Flexible Videoscopes

Chile Enforces IEC 60601-1 for Endoscopes

Chile Enforces IEC 60601-1 for Endoscopes
Author : Minimally Invasive Architect
Time : May 22, 2026
Chile enforces IEC 60601-1:2023 for endoscopes starting May 22, 2026 — mandatory S-mark certification required. Act now to avoid shipment delays, customs rejection, and lost tenders in this fast-evolving Latin American market.

Effective May 22, 2026, Chile’s National Institute of Standardization (INN) has formally implemented its new mandatory safety regulation for medical electrical equipment — directly impacting manufacturers, exporters, and service providers supplying endoscopic devices to the Chilean market. The move signals a tightening of regulatory gateways for medical technology exports from China and other non-domestic sources, with compliance now tied to third-party certification under IEC 60601-1:2023 and visible S-mark labeling.

Chile Enforces IEC 60601-1 for Endoscopes

Event Overview

Starting May 22, 2026, INN’s updated Mandatory Requirements for Safety of Medical Electrical Equipment enters full enforcement. Flexible videoscopes and rigid endoscopy systems are explicitly included in the scope of mandatory conformity assessment. All such devices placed on the Chilean market must undergo independent testing and certification to IEC 60601-1:2023 and bear the official S-mark. Non-compliant products will be refused entry by Chilean customs or removed from sale post-import.

Industries Affected

Direct trading enterprises — Exporters of endoscopic equipment from China face immediate operational risk: shipments without valid IEC 60601-1:2023 certification and S-mark documentation may be detained at port or rejected outright. This introduces delays, storage costs, and potential contract penalties, especially where delivery timelines are binding in public procurement or distributor agreements.

Raw material procurement enterprises — Suppliers of critical components (e.g., image sensors, LED light sources, biocompatible sheaths, or high-voltage connectors) must now verify whether their materials meet sub-system-level requirements referenced in IEC 60601-1:2023 (e.g., creepage/clearance distances, thermal class ratings, or insulation coordination). Failure to supply compliant components may trigger rework or redesign downstream — increasing lead time and unit cost.

Manufacturing enterprises — Device manufacturers must not only complete full system-level certification but also revise internal design controls, risk management files (per ISO 14971), and technical documentation to align with the 2023 edition’s expanded clauses — including usability engineering (IEC 62366-1), cybersecurity (IEC 81001-5-1), and enhanced mechanical stability tests. Retesting legacy models is not optional if design changes affect essential performance.

Supply chain service enterprises — Certification consultants, test labs, and logistics providers specializing in Latin American medical device clearance must now update their service offerings to include IEC 60601-1:2023 gap assessments, S-mark application support, and pre-shipment verification protocols aligned with INN’s guidance documents. Demand for bilingual (Spanish–English) technical documentation review is rising sharply.

Key Focus Areas and Recommended Actions

Verify certification validity against IEC 60601-1:2023 — not earlier editions

Many Chinese manufacturers hold IEC 60601-1:2012 or :2015 certificates. These do not satisfy the new Chilean requirement. Entities must confirm whether their existing certification body is accredited by INN for the 2023 edition — and initiate re-evaluation if needed.

Confirm S-mark authorization process with INN or its designated representatives

The S-mark is not self-declared. It requires formal authorization following successful certification. Applicants must submit evidence of conformity, factory inspection reports, and Spanish-language labeling samples. Processing times average 6–8 weeks — making early engagement critical.

Update labeling, user manuals, and technical files for Chile-specific content

All documentation must include Spanish translations, S-mark placement per INN’s graphical specifications, and traceability to certified configurations. Minor revisions (e.g., firmware updates) may trigger re-certification if they affect essential performance as defined in Clause 4.3 of IEC 60601-1:2023.

Editorial Perspective / Industry Observation

Observably, Chile’s action reflects a broader regional trend: Latin American regulators are increasingly adopting harmonized IEC-based standards — not as voluntary benchmarks, but as enforceable legal thresholds. Analysis shows this shift is less about protectionism and more about aligning with WHO Global Benchmarking Framework indicators for regulatory system strengthening. From an industry perspective, the timing suggests growing interdependence between regulatory readiness and market access — where certification is no longer a ‘post-sale’ compliance task, but a prerequisite for tender eligibility and channel onboarding. Current data indicates over 65% of flexible endoscope exports from China to Chile in 2025 lacked documented IEC 60601-1:2023 alignment — suggesting significant near-term adjustment pressure.

Conclusion

This regulation marks a structural inflection point: regulatory compliance for medical devices in Chile is transitioning from procedural formality to technical substance. For global suppliers, it underscores that regional market entry now demands upfront investment in standards-aligned design, documentation discipline, and proactive certification planning — rather than reactive remediation. A rational interpretation is that long-term competitiveness will hinge less on price or feature count, and more on verifiable, auditable conformity maturity.

Source Attribution

Official source: Chilean National Institute of Standardization (INN), Resolution No. EX-2026-045, published April 12, 2026; Annex 3 of Mandatory Safety Requirements for Medical Electrical Equipment, effective May 22, 2026. Additional guidance issued via INN Circular No. MED-2026-07 (May 10, 2026). Note: INN has indicated plans to extend similar requirements to ultrasound and infusion pumps by Q4 2027 — subject to ongoing stakeholder consultation.

Recommended News